Business
Brent H. Zettl Provides Update on Holdings of ZYUS Life Sciences Corporation
This press release is issued pursuant to the requirements of National Instrument 62-103 – ...
About this update from Zyus Life Sciences Corporation
[{"type":"text","content":"Brent H. Zettl Provides Update on Holdings of ZYUS Life Sciences Corporation\n\n\n .bwalignc { text-align: center; list-style-position: inside }\n \n\n\n\n\n This press release is issued pursuant to the requirements of National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues\n \n\n\n\n\n Mr. Brent H. Zettl (the “\n \n acquiror\n \n ”), who serves as the President and CEO and a director of ZYUS Life Sciences Corporation (“\n \n ZYUS\n \n ”) provides updates to his holdings of Common shares (“\n \n Common Shares\n \n ”) in the capital of ZYUS, Common Share purchase warrants of ZYUS (“\n \n Warrants\n \n ”) and options to purchase Common Shares (“\n \n Options\n \n ”).\n \n\n On June 27, 2025, the acquiror participated in a non-brokered private placement of units (“\n \n Units\n \n ”) of ZYUS (the “\n \n Private Placement\n \n ”) at a price of $0.67 per Unit, with each Unit comprised of one Common Share and one half of one Warrant (each whole Warrant, a “\n \n Private Placement Warrant\n \n ”). Each Private Placement Warrant entitles the holder to acquire one Common Share at a price of $0.95 for a period of twenty-four months from the date of issuance, subject to certain acceleration provisions. The acquiror acquired, indirectly through 1189115 B.C. LTD. 298,507 Units (comprised of 298,507 Common Shares and 149,253 Warrants) under the Private Placement.\n \n\n Immediately prior to the Private Placement, the acquiror owned, directly and indirectly, and exercised control over 33,730,573 Common Shares and 493,108 Options, representing 43.9% of ZYUS’s issued and outstanding Common Shares on an undiluted basis and 44.3% of ZYUS’s issued and outstanding Common Shares on a partially diluted basis (assuming full exercise of all of the convertible securities held by the acquiror). Immediately following the Private Placement and as at the date hereof, the acquiror owns, directly and indirectly, and exercises control over 34,029,080 Common Shares, 149,253 Warrants and 493,108 Options, representing 43.9% of ZYUS’s issued and outstanding Common Shares on an undiluted basis and 44.3% of ZYUS’s issued and outstanding Common Shares on a partially dilut...